Skip to main content
By Allie Nawrat
17 December 2020 (Last Updated December 17th, 2020 20:58)

Unlike the rest of the world, New Zealand’s speedy and decisive response to Covid-19 has successfully enabled the country’s clinical trials to continue largely unscathed. Allie Nawrat talks to key actors in the New Zealand clinical space about how Covid-19 has positively impacted the country’s trial landscape, as well as how to ensure this success is long-term.

Read the Full Article